Up-regulation of Ciliary Neurotrophic Factor in Astrocytes by Aspirin IMPLICATIONS FOR REMYELINATION IN MULTIPLE SCLEROSIS

被引:46
作者
Modi, Khushbu K. [1 ]
Sendtner, Michael [2 ]
Pahan, Kalipada [1 ,3 ]
机构
[1] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[2] Univ Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany
[3] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL 60612 USA
基金
美国国家卫生研究院;
关键词
FIBRILLARY ACIDIC PROTEIN; LIPID-LOWERING DRUG; NEUTRAL SPHINGOMYELINASE; CNTF; DISEASE; CELLS; GEMFIBROZIL; NEURONS; KINASE; CAMP;
D O I
10.1074/jbc.M112.447268
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ciliary neurotrophic factor (CNTF) is a promyelinating trophic factor, and the mechanisms by which CNTF expression could be increased in the brain are poorly understood. Acetylsalicylic acid (aspirin) is one of the most widely used analgesics. Interestingly, aspirin increased mRNA and protein expression of CNTF in primary mouse and human astrocytes in a dose- and time-dependent manner. Aspirin induced the activation of protein kinase A (PKA) but not protein kinase C (PKC). H-89, an inhibitor of PKA, abrogated aspirin-induced expression of CNTF. The activation of cAMP-response element-binding protein (CREB), but not NF-kappa B, by aspirin, the abrogation of aspirin-induced expression of CNTF by siRNA knockdown of CREB, the presence of a consensus cAMP-response element in the promoter of CNTF, and the recruitment of CREB and CREB-binding protein to the CNTF promoter by aspirin suggest that aspirin increases the expression of the Cntf gene via the activation of CREB. Furthermore, we demonstrate that aspirin-induced astroglial CNTF was also functionally active and that supernatants of aspirin-treated astrocytes of wild type, but not Cntf null, mice increased myelin-associated proteins in oligodendrocytes and protected oligodendrocytes from TNF-alpha insult. These results highlight a new and novel myelinogenic property of aspirin, which may be of benefit for multiple sclerosis and other demyelinating disorders.
引用
收藏
页码:18533 / 18545
页数:13
相关论文
共 37 条
[1]   Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients [J].
Aebischer, P ;
Schluep, M ;
Deglon, N ;
Joseph, JM ;
Hirt, L ;
Heyd, B ;
Goddard, M ;
Hammang, JP ;
Zurn, AD ;
Kato, AC ;
Regli, F ;
Baetge, EE .
NATURE MEDICINE, 1996, 2 (06) :696-699
[2]   Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice [J].
Aubin, N ;
Curet, O ;
Deffois, A ;
Carter, C .
JOURNAL OF NEUROCHEMISTRY, 1998, 71 (04) :1635-1642
[3]   Aspirin-induced blockade of NF-κB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells [J].
Bae, Moon-Kyoung ;
Kim, Su-Ryun ;
Lee, Hak-Joong ;
Wee, Hee-Jun ;
Yoo, Mi-Ae ;
Oh, Sae Ock ;
Baek, Sun-Yong ;
Kim, Bong-Seon ;
Kim, Jae-Bong ;
Sik-Yoon ;
Bae, Soo-Kyung .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2006, 1763 (03) :282-289
[4]  
BARRES BA, 1993, DEVELOPMENT, V118, P283
[5]   Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide [J].
Brahmachari, S ;
Fung, YK ;
Pahan, K .
JOURNAL OF NEUROSCIENCE, 2006, 26 (18) :4930-4939
[6]   Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Reduces Microglial and Astroglial Inflammatory Responses [J].
Brahmachari, Saurav ;
Jana, Arundhati ;
Pahan, Kalipada .
JOURNAL OF IMMUNOLOGY, 2009, 183 (09) :5917-5927
[7]  
BUDD JS, 1993, J ROY SOC MED, V86, P261
[8]   Gemfibrozil, a Lipid-Lowering Drug, Upregulates IL-1 Receptor Antagonist in Mouse Cortical Neurons: Implications for Neuronal Self-Defense [J].
Corbett, Grant T. ;
Roy, Avik ;
Pahan, Kalipada .
JOURNAL OF IMMUNOLOGY, 2012, 189 (02) :1002-1013
[9]   Misalignment of PLP/DM20 Transmembrane Domains Determines Protein Misfolding in Pelizaeus-Merzbacher Disease [J].
Dhaunchak, Ajit Singh ;
Colman, David R. ;
Nave, Klaus-Armin .
JOURNAL OF NEUROSCIENCE, 2011, 31 (42) :14961-14971
[10]   Intracompartmental delivery of CNTF as therapy for Huntingtons disease and retinitis pigmentosa [J].
Emerich, DF ;
Thanos, CG .
CURRENT GENE THERAPY, 2006, 6 (01) :147-159